These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32964999)

  • 1. Treatment of BRONJ with ozone/oxygen therapy and debridement with piezoelectric surgery.
    Goker F; Donati G; Grecchi F; Sparaco A; Ghezzi M; Rania V; Rossi CA; Del Fabbro M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9094-9103. PubMed ID: 32964999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.
    Lee LW; Hsiao SH; Chen LK
    J Formos Med Assoc; 2014 Mar; 113(3):166-72. PubMed ID: 24630034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy.
    Agrillo A; Filiaci F; Ramieri V; Riccardi E; Quarato D; Rinna C; Gennaro P; Cascino F; Mitro V; Ungari C
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1741-7. PubMed ID: 23161050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P; Nammour S
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ozone infiltration as an adjunctive treatment to piezoelectric surgery in the management of medication-related osteonecrosis of the jaws: case series of 29 patients.
    Goker F; Donati G; Gallo F; Sparaco A; Rania V; Busa A; Grecchi F; Grecchi E; Colapinto G; Del Fabbro M
    Oral Maxillofac Surg; 2024 Mar; ():. PubMed ID: 38523198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
    Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
    Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.
    Silva LF; Curra C; Munerato MS; Deantoni CC; Matsumoto MA; Cardoso CL; Curi MM
    Oral Maxillofac Surg; 2016 Mar; 20(1):9-17. PubMed ID: 26659615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites.
    Blus C; Giannelli G; Szmukler-Moncler S; Orru G
    Oral Maxillofac Surg; 2017 Mar; 21(1):41-48. PubMed ID: 27924427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
    Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
    Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
    Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis.
    de Souza Faloni AP; Queiroz TP; Comelli Lia RC; Cerri PS; Margonar R; Rastelli AN; Marcantonio E
    J Craniofac Surg; 2011 Nov; 22(6):2185-90. PubMed ID: 22075816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
    Gil IG; Ponte BM; Mateo ST; García JJ
    J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.
    Zang X; He L; Zhao L; He Y; Xiao E; Zhang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):169. PubMed ID: 31196208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines.
    Patel S; Choyee S; Uyanne J; Nguyen AL; Lee P; Sedghizadeh PP; Kumar SK; Lytle J; Shi S; Le AD
    Oral Dis; 2012 Oct; 18(7):625-32. PubMed ID: 22420684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonate-associated osteonecrosis of the jaw].
    Koy S; Schubert M; Koy J; Ney M; Lauer G; Sabatowski R
    Schmerz; 2015 Apr; 29(2):171-8. PubMed ID: 25860198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: report of a case.
    Fatema CN; Sato J; Yamazaki Y; Hata H; Hattori N; Shiga T; Tamaki N; Kitagawa Y
    Odontology; 2015 Jan; 103(1):105-8. PubMed ID: 23907202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.